These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37422431)

  • 1. Airway infections as a risk factor for Pseudomonas aeruginosa acquisition and chronic colonisation in children with cystic fibrosis.
    Mésinèle J; Ruffin M; Guillot L; Boëlle PY; Corvol H
    J Cyst Fibros; 2023 Sep; 22(5):901-908. PubMed ID: 37422431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seasonality of acquisition of respiratory bacterial pathogens in young children with cystic fibrosis.
    Psoter KJ; De Roos AJ; Wakefield J; Mayer JD; Rosenfeld M
    BMC Infect Dis; 2017 Jun; 17(1):411. PubMed ID: 28599639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for Pseudomonas aeruginosa airway infection and lung function decline in children with cystic fibrosis.
    Mésinèle J; Ruffin M; Kemgang A; Guillot L; Boëlle PY; Corvol H
    J Cyst Fibros; 2022 Jan; 21(1):45-51. PubMed ID: 34629287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Air pollution exposure is associated with MRSA acquisition in young U.S. children with cystic fibrosis.
    Psoter KJ; De Roos AJ; Wakefield J; Mayer JD; Rosenfeld M
    BMC Pulm Med; 2017 Jul; 17(1):106. PubMed ID: 28750627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between Staphylococcus aureus alone or combined with Pseudomonas aeruginosa and the clinical condition of patients with cystic fibrosis.
    Hubert D; Réglier-Poupet H; Sermet-Gaudelus I; Ferroni A; Le Bourgeois M; Burgel PR; Serreau R; Dusser D; Poyart C; Coste J
    J Cyst Fibros; 2013 Sep; 12(5):497-503. PubMed ID: 23291443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethnic differences in staphylococcus aureus acquisition in cystic fibrosis.
    McGarry ME; Huang CY; Ly NP
    J Cyst Fibros; 2023 Sep; 22(5):909-915. PubMed ID: 37460380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes after initial pseudomonas acquisition in cystic fibrosis.
    Zemanick ET; Emerson J; Thompson V; McNamara S; Morgan W; Gibson RL; Rosenfeld M;
    Pediatr Pulmonol; 2015 Jan; 50(1):42-8. PubMed ID: 24644274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-colonisation with Aspergillus fumigatus and Pseudomonas aeruginosa is associated with poorer health in cystic fibrosis patients: an Irish registry analysis.
    Reece E; Segurado R; Jackson A; McClean S; Renwick J; Greally P
    BMC Pulm Med; 2017 Apr; 17(1):70. PubMed ID: 28431569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changing Epidemiology of the Respiratory Bacteriology of Patients With Cystic Fibrosis.
    Salsgiver EL; Fink AK; Knapp EA; LiPuma JJ; Olivier KN; Marshall BC; Saiman L
    Chest; 2016 Feb; 149(2):390-400. PubMed ID: 26203598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Respiratory microbiology of patients with cystic fibrosis in the United States, 1995 to 2005.
    Razvi S; Quittell L; Sewall A; Quinton H; Marshall B; Saiman L
    Chest; 2009 Dec; 136(6):1554-1560. PubMed ID: 19505987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial Culture Underestimates Lung Pathogen Detection and Infection Status in Cystic Fibrosis.
    Gavillet H; Hatfield L; Rivett D; Jones A; Maitra A; Horsley A; van der Gast C
    Microbiol Spectr; 2022 Oct; 10(5):e0041922. PubMed ID: 35972283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of colonizing organism in the respiratory tract on the incidence, duration, and time between subsequent hospitalizations among patients with cystic fibrosis.
    Cios K; Cohen B; Quittell LM; Liu J; Larson EL
    Am J Infect Control; 2019 Jul; 47(7):750-754. PubMed ID: 30732978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibacterial potential of
    Crisan CV; Pettis ML; Goldberg JB
    mSphere; 2024 Jul; 9(7):e0033524. PubMed ID: 38980073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicenter Observational Study on Factors and Outcomes Associated with Various Methicillin-Resistant Staphylococcus aureus Types in Children with Cystic Fibrosis.
    Muhlebach MS; Heltshe SL; Popowitch EB; Miller MB; Thompson V; Kloster M; Ferkol T; Hoover WC; Schechter MS; Saiman L;
    Ann Am Thorac Soc; 2015 Jun; 12(6):864-71. PubMed ID: 25745825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practical Guidance for Clinical Microbiology Laboratories: Updated guidance for processing respiratory tract samples from people with cystic fibrosis.
    Saiman L; Waters V; LiPuma JJ; Hoffman LR; Alby K; Zhang SX; Yau YC; Downey DG; Sermet-Gaudelus I; Bouchara J-P; Kidd TJ; Bell SC; Brown AW
    Clin Microbiol Rev; 2024 Sep; 37(3):e0021521. PubMed ID: 39158301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Intensity of Antipseudomonal Antibiotic Therapy With Risk of Treatment-Emergent Organisms in Children With Cystic Fibrosis and Newly Acquired Pseudomonas Aeruginosa.
    Cogen JD; Onchiri FM; Hamblett NM; Gibson RL; Morgan WJ; Rosenfeld M
    Clin Infect Dis; 2021 Sep; 73(6):987-993. PubMed ID: 33693586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and laboratory correlations in patients with cystic fibrosis and Pseudomonas aeruginosa infection: The experience of a regional centre.
    Smădeanu R; Moşescu S; Zăpucioiu C; Orăşeanu D
    Pneumologia; 2016; 65(4):201-6. PubMed ID: 29542902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A longitudinal analysis of chronic MRSA and Pseudomonas aeruginosa co-infection in cystic fibrosis: A single-center study.
    Maliniak ML; Stecenko AA; McCarty NA
    J Cyst Fibros; 2016 May; 15(3):350-6. PubMed ID: 26610860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Palivizumab prophylaxis in infants with cystic fibrosis does not delay first isolation of Pseudomonas aeruginosa or Staphylococcus aureus.
    Buchs C; Dalphin ML; Sanchez S; Perceval M; Coutier L; Mainguy C; Kassaï-Koupaï B; Reix P
    Eur J Pediatr; 2017 Jul; 176(7):891-897. PubMed ID: 28508992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scorpionfish BPI is highly active against multiple drug-resistant
    Holzinger JM; Toelge M; Werner M; Ederer KU; Siegmund HI; Peterhoff D; Blaas SH; Gisch N; Brochhausen C; Gessner A; Bülow S
    Elife; 2023 Jul; 12():. PubMed ID: 37461324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.